Symbravo

Active Ingredient(s): Meloxicam + Rizatriptan Benzoate
FDA Approved: * January 30, 2025
Pharm Company: * AXSOME
Category: Migraine / Tension Headache
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Symbravo Oral Tablet
NDC: 81968-020
Labeler:
Axsome Therapeutics, Inc.